The objective of the study is to refine our knowledge on the physiopathology of the symptoms and the complications for the patients affected by a drepanocytic syndrome.
The establishment of risk factors and indicators of severity will allow to target better the patients requiring an adequate strategy in order to prevent the installation of some complications or to limit their worsening.
| Béatrice BG Gulbis, Phd MD | |
| +32 02 555 34 27 | |
| [email protected] |
| Jonathan JB Brauner, Md | |
| +32 02 555 34 27 | |
| [email protected] |
27 Belgium sites
> 17 Years
Observational
All
Genetic
Patients 18 years or older with sickle cell syndrome
Signing an inform consent form after validation on it by the Ethics Committees of the participating centers.
Any pathology concomitant risk of nephropathy
Severe CVO within the month preceding the sampling
Transfusions within 3 months prior to sampling
Pregnant patient or within 3 months post- accouhcement